Related Experiment Videos
Type 2 diabetes and pneumonia outcomes: a population-based cohort study
Jette B Kornum1, Reimar W Thomsen, Anders Riis
1Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg, Denmark. j.kornum@rn.dk
Diabetes Care
|June 28, 2007
Summary
Type 2 diabetes increases pneumonia mortality risk. High blood sugar on admission also predicts death, especially in non-diabetic patients, highlighting the importance of glucose control in pneumonia care.
Area of Science:
- Internal Medicine
- Endocrinology
- Public Health
Background:
- Type 2 diabetes is a growing global health concern.
- Pneumonia remains a leading cause of infectious disease mortality.
- The interplay between diabetes and pneumonia outcomes requires further investigation.
Purpose of the Study:
- To determine if type 2 diabetes elevates the risk of mortality and complications post-pneumonia hospitalization.
- To evaluate the predictive value of hyperglycemia upon admission for pneumonia outcomes.
Main Methods:
- Population-based cohort study of 29,900 adults hospitalized for pneumonia (1997-2004).
- Utilized regression analysis to calculate adjusted mortality rate ratios (MRRs) for patients with and without type 2 diabetes.
- Investigated admission hyperglycemia's prognostic impact in a subcohort of 13,574 patients.
Main Results:
- Patients with type 2 diabetes exhibited higher 30-day (19.9% vs. 15.1%) and 90-day (27.0% vs. 21.6%) mortality rates.
- Type 2 diabetes did not predict pulmonary complications or bacteremia.
- Admission hyperglycemia was a significant predictor of mortality, particularly in patients without diagnosed diabetes.
Conclusions:
- Type 2 diabetes is an independent predictor of increased mortality following pneumonia.
- Hyperglycemia at hospital admission is a critical prognostic factor for pneumonia-related death.
- Glycemic control may be crucial for improving outcomes in pneumonia patients.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...